Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	38.42B
Revenue (ttm)	5.95B
Net Income (ttm)	993.59M
Shares Out	359.15M
EPS (ttm)	2.82
PE Ratio	38.40
Forward PE	33.24
Dividend	1.10 (1.02%)
Ex-Dividend Date	Jun 26, 2025

Volume	11,343,686
Average Volume	11,110,028
Open	101.00
Previous Close	107.80
Day's Range	101.00 - 112.20
52-Week Range	59.55 - 125.50
Beta	0.27
RSI	55.72
Earnings Date	Aug 26, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.